Calcium sennoside

CAS: 62211-03-4

Ref. 3D-FC31232

Produktinformation

• Name: Calcium sennoside
• Synonyme: Calcium (R*,R*)-5,5'-bis(beta-D-glucopyranosyloxy)-9,9',10,10'-tetrahydro-4,4'-dihydroxy-10,10'-dioxo(9,9'-bianthracene)-2,2'-dicarboxylate, Pursennid, Pursennide, Sennoside Ca, [9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-, [9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-<span class="text-smallcaps">D</span>-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (R*,R*)-, calcium 5,5'-bis(beta-D-glucopyranosyloxy)-4,4'-dihydroxy-10,10'-dioxo-9,9',10,10'-tetrahydro-9,9'-bianthracene-2,2'-dicarboxylate

Beschreibung

Calcium sennoside is a naturally occurring compound that has been shown to increase the energy metabolism in hepatocytes and to reduce hepatic steatosis, which is the accumulation of fat in the liver. It has also been shown to have a matrix effect on cancer cells, which means that it can inhibit tumor growth by causing changes in the extracellular environment around a tumor cell. Calcium sennoside regulates PGE2 levels and body mass index (BMI) by increasing energy expenditure and decreasing fat storage. It is chemically stable and does not hydrolyze or degrade under normal conditions. The optimum extraction process for calcium sennoside includes trifluoroacetic acid (TFA) and sodium carbonate (NaCO).

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 868.8 g/mol
• Formel: C₄₂H₃₆CaO₁₈
• Reinheit: Min. 95%